Dabigatran Challenges Warfarin's Superiority for Stroke Prevention in Atrial Fibrillation

Stroke - United States
doi 10.1161/strokeaha.110.584557
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Stroke Prevention in Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2010English

Stroke Prevention in Atrial Fibrillation

International Journal of Arrhythmia
2017English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Stroke Prevention in Atrial Fibrillation Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2012English

Treatments for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis and Indirect Comparisons Versus Dabigatran Etexilate

Thrombosis and Haemostasis
Hematology
2010English

Stroke Detection and Prevention in Atrial Fibrillation

British Journal of General Practice
MedicineFamily Practice
2015English

Stroke Prevention in Atrial Fibrillation: An Asian Perspective

Thrombosis and Haemostasis
Hematology
2014English

Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy